×
Psychiatry Residency Application in the COVID-19 Era: A Medical Student Conundrum PDF
$ 40.00
Psychiatry Residency Application in the COVID-19 Era: A Medical Student Conundrum PDF quantity
$ 40.00
×
Obsessive-Compulsive Hoarding: Symptom Severity and Response to Multimodal Treatment PDF
$ 40.00
Obsessive-Compulsive Hoarding: Symptom Severity and Response to Multimodal Treatment PDF quantity
$ 40.00
×
Prenatal Care and Adverse Pregnancy Outcomes Among Women With Schizophrenia: A Nationwide Population-Based Study in Taiwan PDF
$ 40.00
Prenatal Care and Adverse Pregnancy Outcomes Among Women With Schizophrenia: A Nationwide Population-Based Study in Taiwan PDF quantity
$ 40.00
×
Paroxetine in the Treatment of Chronic Posttraumatic Stress Disorder: Results of a Placebo-Controlled, Flexible-Dosage Trial PDF
$ 40.00
Paroxetine in the Treatment of Chronic Posttraumatic Stress Disorder: Results of a Placebo-Controlled, Flexible-Dosage Trial PDF quantity
$ 40.00
×
Venlafaxine in Dysthymic Disorder PDF
$ 40.00
Venlafaxine in Dysthymic Disorder PDF quantity
$ 40.00
×
Psychogenic Nonepileptic Seizures: A Complex Diagnosis and Comprehensive Review PDF
$ 40.00
Psychogenic Nonepileptic Seizures: A Complex Diagnosis and Comprehensive Review PDF quantity
$ 40.00
×
The Evolution of the Psychiatry Research Journal PDF
$ 40.00
The Evolution of the Psychiatry Research Journal PDF quantity
$ 40.00
×
Correlates of Incident Bipolar Disorder in Children and Adolescents Diagnosed With Attention-Deficit/Hyperactivity Disorder PDF
$ 40.00
Correlates of Incident Bipolar Disorder in Children and Adolescents Diagnosed With Attention-Deficit/Hyperactivity Disorder PDF quantity
$ 40.00
×
Efficacy and Safety of Risperidone in the Treatment of Schizoaffective Disorder: Initial Results From a Large, Multicenter Surveillance Study PDF
$ 40.00
Efficacy and Safety of Risperidone in the Treatment of Schizoaffective Disorder: Initial Results From a Large, Multicenter Surveillance Study PDF quantity
$ 40.00
×
Ziprasidone in Treatment-Resistant Schizophrenia: A 52-Week, Open-Label Continuation Study PDF
$ 40.00
Ziprasidone in Treatment-Resistant Schizophrenia: A 52-Week, Open-Label Continuation Study PDF quantity
$ 40.00
×
Prevalence of Negative Symptoms in Outpatients With Schizophrenia Spectrum Disorders Treated With Antipsychotics in Routine Clinical Practice: Findings From the CLAMORS Study PDF
$ 40.00
Prevalence of Negative Symptoms in Outpatients With Schizophrenia Spectrum Disorders Treated With Antipsychotics in Routine Clinical Practice: Findings From the CLAMORS Study PDF quantity
$ 40.00
×
Short Sleep in Patients With Chronic Paranoid Schizophrenia PDF
$ 40.00
Short Sleep in Patients With Chronic Paranoid Schizophrenia PDF quantity
$ 40.00
×
Possible Basal Ganglia Pathology in Children With Complex Symptoms PDF
$ 40.00
Possible Basal Ganglia Pathology in Children With Complex Symptoms PDF quantity
$ 40.00
×
A 3-Month, Randomized, Placebo-Controlled, Neuroleptic Discontinuation Study in 100 People With Dementia: The Neuropsychiatric Inventory Median Cutoff Is a Predictor of Clinical Outcome PDF
$ 40.00
A 3-Month, Randomized, Placebo-Controlled, Neuroleptic Discontinuation Study in 100 People With Dementia: The Neuropsychiatric Inventory Median Cutoff Is a Predictor of Clinical Outcome PDF quantity
$ 40.00
×
The Relationship Between Suicide Attempts and Borderline Personality in Gastric Surgery Candidates PDF
$ 40.00
The Relationship Between Suicide Attempts and Borderline Personality in Gastric Surgery Candidates PDF quantity
$ 40.00
×
The Impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on Prescribing Practices: An Analysis of Data From a Large Midwestern State PDF
$ 40.00
The Impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on Prescribing Practices: An Analysis of Data From a Large Midwestern State PDF quantity
$ 40.00
×
Shared Decision Making and Long-Term Outcome in Schizophrenia Treatment PDF
$ 40.00
Shared Decision Making and Long-Term Outcome in Schizophrenia Treatment PDF quantity
$ 40.00
×
Treating Child Bipolar Disorder Symptoms | Psychiatrist.com PDF
$ 40.00
Treating Child Bipolar Disorder Symptoms | Psychiatrist.com PDF quantity
$ 40.00
×
Duloxetine, 60 mg Once Daily, for Major Depressive Disorder: A Randomized Double-Blind Placebo-Controlled Trial PDF
$ 40.00
Duloxetine, 60 mg Once Daily, for Major Depressive Disorder: A Randomized Double-Blind Placebo-Controlled Trial PDF quantity
$ 40.00
×
The Effect of Antipsychotic Treatment on Recurrent Venous Thromboembolic Disease: A Cohort Study PDF
$ 40.00
The Effect of Antipsychotic Treatment on Recurrent Venous Thromboembolic Disease: A Cohort Study PDF quantity
$ 40.00
×
Prolactin—A Biomarker for Antipsychotic Treatment Response? PDF
$ 40.00
Prolactin—A Biomarker for Antipsychotic Treatment Response? PDF quantity
$ 40.00
×
Sertraline and Norsertraline Levels in Three Breastfed Infants PDF
$ 40.00
Sertraline and Norsertraline Levels in Three Breastfed Infants PDF quantity
$ 40.00
×
Injections of Depot Antipsychotic Medications in Patients Suffering From Schizophrenia: Do They Hurt? PDF
$ 40.00
Injections of Depot Antipsychotic Medications in Patients Suffering From Schizophrenia: Do They Hurt? PDF quantity
$ 40.00
×
Thinking Outside the Box About Young Female Patients With Sudden-Onset Bizarre Behavior: A Case of Anti-N -Methyl-d-Aspartate Receptor Encephalitis PDF
$ 40.00
Thinking Outside the Box About Young Female Patients With Sudden-Onset Bizarre Behavior: A Case of Anti-N-Methyl-d-Aspartate Receptor Encephalitis PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart